Please login to the form below

Not currently logged in
Email:
Password:

dostarlimab

This page shows the latest dostarlimab news and features for those working in and with pharma, biotech and healthcare.

GSK’s Jemperli combination receives FDA approval for endometrial cancer

GSK’s Jemperli combination receives FDA approval for endometrial cancer

GSK’s Jemperli (dostarlimab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA) for previously untreated, primary advanced or recurrent endometrial cancer. ... Last month, GSK announced that the same patient

Latest news

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....